Technical Analysis for BFRG - Bullfrog AI Holdings, Inc

Grade Last Price % Change Price Change
B 3.39 13.38% 0.40
BFRG closed up 13.38 percent on Friday, March 31, 2023, on 2.15 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
180 Bullish Setup Bullish Swing Setup 13.38%
Pocket Pivot Bullish Swing Setup 13.38%
Inside Day Range Contraction 13.38%
Wide Bands Range Expansion 13.38%
20 DMA Resistance Bearish 25.09%
Wide Bands Range Expansion 25.09%
Oversold Stochastic Weakness 25.09%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Bullfrog AI Holdings, Inc Description

BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.


Sector: Healthcare
Industry: Health Information Services
Keywords: Medicine Artificial Intelligence Machine Learning Obesity Steatohepatitis Hepatitis Human Diseases Non Alcoholic Fatty Liver Disease Liver Disease Hepatocellular Carcinoma Histopathology Fatty Liver Disease Si RNA Treatment Of Human Diseases

Is BFRG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 5.83
52 Week Low 2.47
Average Volume 437,450
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 3.13
10-Day Moving Average 2.84
Average True Range 0.54
RSI 49.49
ADX 22.68
+DI 22.55
-DI 18.92
Chandelier Exit (Long, 3 ATRs) 2.90
Chandelier Exit (Short, 3 ATRs) 4.08
Upper Bollinger Bands 4.17
Lower Bollinger Band 2.10
Percent B (%b) 0.62
BandWidth 66.06
MACD Line -0.27
MACD Signal Line -0.34
MACD Histogram 0.0719
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.64
Resistance 3 (R3) 4.58 4.11 4.43
Resistance 2 (R2) 4.11 3.79 4.14 4.36
Resistance 1 (R1) 3.75 3.60 3.93 3.81 4.29
Pivot Point 3.28 3.28 3.37 3.31 3.28
Support 1 (S1) 2.92 2.96 3.10 2.98 2.49
Support 2 (S2) 2.45 2.77 2.48 2.42
Support 3 (S3) 2.09 2.45 2.35
Support 4 (S4) 2.15